TCM Ltd
Incorporated in 1943, TCM Ltd manufactures chemicals having and trades solar equipments and healthcare devices[1]
- Market Cap ₹ 31.5 Cr.
- Current Price ₹ 42.1
- High / Low ₹ 67.0 / 35.7
- Stock P/E
- Book Value ₹ 46.2
- Dividend Yield 0.00 %
- ROCE 1.08 %
- ROE 0.58 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.91 times its book value
- Debtor days have improved from 177 to 97.4 days.
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -4.49% over last 3 years.
- Company's cost of borrowing seems high
- Working capital days have increased from -332 days to 99.4 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.40 | 0.92 | 4.23 | 3.46 | 7.16 | 31.65 | 29.50 | |
0.99 | 1.22 | 0.43 | 0.50 | 0.72 | 0.35 | 1.26 | 1.67 | 4.27 | 5.78 | 9.71 | 32.02 | 30.39 | |
Operating Profit | -0.97 | -1.22 | -0.43 | -0.50 | -0.72 | -0.35 | -0.86 | -0.75 | -0.04 | -2.32 | -2.55 | -0.37 | -0.89 |
OPM % | -4,850.00% | -215.00% | -81.52% | -0.95% | -67.05% | -35.61% | -1.17% | -3.02% | |||||
-1.16 | 0.05 | 0.02 | 0.06 | 0.22 | -0.39 | 0.04 | 1.15 | 1.23 | -1.56 | 0.23 | 0.82 | 0.87 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.01 | 0.12 | 0.01 | 0.01 | 0.01 | 0.27 | 0.14 | 0.14 |
Depreciation | 0.28 | 0.28 | 0.07 | 0.06 | 0.06 | 0.00 | 0.00 | 0.01 | 0.02 | 0.04 | 0.19 | 0.07 | 0.08 |
Profit before tax | -2.41 | -1.45 | -0.48 | -0.50 | -0.61 | -0.75 | -0.94 | 0.38 | 1.16 | -3.93 | -2.78 | 0.24 | -0.24 |
Tax % | -2.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 15.52% | 0.00% | -0.72% | 16.67% | |
-2.34 | -1.44 | -0.48 | -0.50 | -0.61 | -0.75 | -0.95 | 0.39 | 0.98 | -3.93 | -2.77 | 0.20 | -0.27 | |
EPS in Rs | -3.12 | -1.92 | -0.64 | -0.67 | -0.81 | -1.00 | -1.27 | 0.52 | 1.31 | -5.24 | -3.70 | 0.27 | -0.36 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 140% |
3 Years: | 96% |
TTM: | 114% |
Compounded Profit Growth | |
---|---|
10 Years: | 8% |
5 Years: | 17% |
3 Years: | -33% |
TTM: | 84% |
Stock Price CAGR | |
---|---|
10 Years: | 3% |
5 Years: | 7% |
3 Years: | 5% |
1 Year: | 4% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -2% |
3 Years: | -4% |
Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 7.48 | 7.48 |
Reserves | -26.25 | -27.69 | -29.20 | -29.70 | -30.31 | 30.33 | 29.02 | 29.16 | 30.14 | 23.73 | 26.90 | 27.10 |
23.94 | 24.28 | 24.69 | 25.15 | 6.30 | 5.38 | 5.38 | 5.64 | 5.83 | 6.02 | 1.08 | 0.27 | |
6.57 | 7.26 | 7.28 | 7.29 | 26.73 | 25.74 | 31.35 | 27.23 | 29.14 | 30.19 | 37.04 | 54.92 | |
Total Liabilities | 7.66 | 7.25 | 6.17 | 6.14 | 6.12 | 64.85 | 69.15 | 65.43 | 68.51 | 63.34 | 72.50 | 89.77 |
2.77 | 2.49 | 1.39 | 1.33 | 1.26 | 58.01 | 58.01 | 58.01 | 58.42 | 54.70 | 35.12 | 16.85 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.80 | 0.44 | 0.19 | 0.19 | 0.17 | 0.52 | 0.91 |
4.65 | 4.52 | 4.54 | 4.57 | 4.62 | 6.04 | 10.70 | 7.23 | 9.90 | 8.47 | 36.86 | 72.01 | |
Total Assets | 7.66 | 7.25 | 6.17 | 6.14 | 6.12 | 64.85 | 69.15 | 65.43 | 68.51 | 63.34 | 72.50 | 89.77 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -0.31 | -0.40 | -0.43 | -0.72 | -4.39 | -1.63 | -0.56 | -0.11 | -2.79 | -9.56 | 3.74 | |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.98 | -0.01 | -0.01 | -0.04 | 2.81 | 4.39 | -2.78 | |
0.50 | 0.32 | 0.41 | 0.47 | 0.83 | 0.15 | 5.32 | -3.14 | 0.18 | 0.20 | 4.99 | -0.94 | |
Net Cash Flow | 0.00 | 0.01 | 0.01 | 0.03 | 0.10 | -0.25 | 3.68 | -3.70 | 0.03 | 0.22 | -0.18 | 0.01 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 27,557.50 | 1,377.88 | 706.20 | 217.45 | 195.16 | 238.07 | 97.45 | |||||
Inventory Days | 1,477.38 | 847.92 | 467.90 | 192.33 | 269.13 | 480.07 | ||||||
Days Payable | 2,581.07 | 1,914.85 | 747.47 | 65.98 | 71.72 | 42.86 | ||||||
Cash Conversion Cycle | 27,557.50 | 274.18 | -360.73 | -62.13 | 321.51 | 435.48 | 534.66 | |||||
Working Capital Days | -72,817.50 | -6,077.25 | -972.01 | -309.78 | -674.09 | -422.60 | 99.41 | |||||
ROCE % | -61.04% | -268.52% | -1.30% | -2.13% | 1.03% | 2.04% | -4.72% | -7.32% | 1.08% |
Documents
Announcements
- Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, 27Th August 2024 1d
- Intimation For Book Closure For The Purpose Of 80Th Annual General Meeting Of The Company To Be Held On Friday, 27Th September 2024 19 Aug
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Aug - Copies of Newspaper clippings regarding Unaudited Consolidated and Standalone Financial Results for the Quarter ended 30th June 2024 published on Thursday, 15th August 2024 in …
- Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th August 2024 And The Consolidated And Standalone Unaudited Financial Results And Limited Review Reports For The Quarter Ended 30Th June 2024 14 Aug
- Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For Quarter Ended 30Th June 2024 8 Aug
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
-
Financial Year 2007
from bse
Business Overview:[1]
Company trading of medical products,
GPS-enabled Automatic Headlight Beam Assist System for vehicles under the brand name of ENSO, and the business of setting up and commissioning Solar Power plants